FDA Phase Out of Animal Test Requirements for Drugs Begins With Biologics
The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab-on-a-chip tests, the agency is encouraging drug companies to use computer simulations and artificial intelligence to predict drug behavior.
